Showing results (151-160 of 196) with videos related to
Sort By:
Pageof 20
Molecular Cancer Therapeutics|May 20, 2016
Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple MyelomaNicola Amodio, Maria Angelica Stamato, Anna Maria Gullà, et al.Cancers|February 6, 2020
The Non-Coding RNA Landscape of Plasma Cell DyscrasiasEugenio Morelli, Annamaria Gullà, Roberta Rocca, et al.Leukemia|March 1, 2018
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activityNicola Amodio, Maria Angelica Stamato, Giada Juli, et al.Journal of Experimental & Clinical Cancer Research : CR|March 26, 2023
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myelomaFrancesca Scionti, Giada Juli, Roberta Rocca, et al.Cancer Immunology, Immunotherapy : CII|June 3, 2015
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patientsMaria Grazia Cusi, Cirino Botta, Pierpaolo Pastina, et al.Oncotarget|May 15, 2018
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccinePierpaolo Correale, Cirino Botta, Nicoletta Staropoli, et al.Leukemia|August 19, 2018
miR-22 suppresses DNA ligase III addiction in multiple myelomaDaniele Caracciolo, Maria Teresa Di Martino, Nicola Amodio, et al.La Radiologia Medica|February 14, 2023
The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a reviewValerio Nardone, Caterina Romeo, Emma D'Ippolito, et al.Journal of Translational Medicine|October 23, 2022
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid RhamnetinDaniele Caracciolo, Giada Juli, Caterina Riillo, et al.International Journal of Molecular Sciences|February 24, 2024
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular CarcinomaLydia Giannitrapani, Francesca Di Gaudio, Melchiorre Cervello, et al.Pageof 20